痛风,尿酸和冠状动脉疾病
Takuya Nakahashi1, Hayato Tada2, Kenji Sakata2
1Division of Cardiology, Department of Internal Medicine, Takaoka City Hospital.
Journal of atherosclerosis and thrombosis
|August 31, 2025
概括
高血清尿酸 (高尿血) 与心血管疾病和死亡率有关. 识别受益于尿酸降低的患者对于控制残留心血管风险至关重要.
科学领域:
- 心脏病学
- 生物化学
- 关节病学
背景情况:
- 血清尿酸高于7.0 mg/dL的高尿血是痛风的前体.
- 它与高血压,糖尿病,脱脂症和死亡率的增加有关.
- 升高的UA与动脉样硬化标志物和内皮功能障碍相关,这表明病原性与心血管事件的联系.
研究的目的:
- 审查目前对冠状动脉疾病 (CAD) 的理解.
- 讨论未来治疗多尿血症作为CAD患者残留风险因素的前景.
主要方法:
- 关于高尿血和心血管疾病的现有证据的文献综述.
- 分析UA升高与心血管不良事件之间的病原性联系.
- 对痛风,酸盐 (MSU) 水晶沉积和心血管影响的检查.
主要成果:
- 高尿血与心血管疾病 (CVD) 的增加率和死亡率有关.
- 在冠状动脉中发生MSU晶体沉积,而不仅仅是关节.
- 目前的尿酸降低疗法在降低高尿血症的心血管事件方面缺乏有效性.
结论:
- 在患有CAD的患者中,高尿血症具有显著的残留风险.
- 确定受益于UA减少的特定患者子组至关重要.
- 需要进行进一步的研究,以建立在CAD中高尿血的有效治疗策略.
相关概念视频
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Coronary Artery Disease III: Clinical Manifestations
31
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
Peripheral Artery Disease I: Introduction
32
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
32


